MedPath

Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of depression.

Phase 3
Recruiting
Conditions
Depression.
Mental Health - Depression
Registration Number
ACTRN12605000145606
Lead Sponsor
Centre for Clinical Research in Neuropsychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rating scales for depression for clinicians (Hamilton 21 point).[Before and after four weeks of treatment.];Rating scales for depression, self administered (Beck Depression Inventory).[Before and after four weeks of treatment.]
Secondary Outcome Measures
NameTimeMethod
EEG recordings and a battery of cognition tests will also be administered.[Prior to treatment, after 4 weeks treatment, and 6 months post treatment.]
© Copyright 2025. All Rights Reserved by MedPath